| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/27/2007 | US20070299249 Polymer Particles |
| 12/27/2007 | US20070299248 Calcium phosphate cements comprising an osteoclastogenic agent |
| 12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
| 12/27/2007 | US20070299245 P277 peptide formulations or variants thereof having optimized stability |
| 12/27/2007 | US20070299244 Liposome allowing liposome-entrapped substance to escape from endosome |
| 12/27/2007 | US20070299097 Strategy for Leukemia Therapy |
| 12/27/2007 | US20070299026 Immunosuppressive Cytokine |
| 12/27/2007 | US20070299025 Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin |
| 12/27/2007 | US20070299023 P185Neu-Encoding Dna and Therapeutical Uses Thereof |
| 12/27/2007 | US20070299016 Specific Antibodies for Diagnosing Heart Failure |
| 12/27/2007 | US20070299008 Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells |
| 12/27/2007 | US20070299007 Muteins OF Fibroblast Growth Factor 21 |
| 12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
| 12/27/2007 | US20070299001 PURIFIED hCG |
| 12/27/2007 | US20070298973 Methods and compositions comprising Renilla GFP |
| 12/27/2007 | US20070298499 Methods and compositions for regulating gene expression in plant cells |
| 12/27/2007 | US20070298494 Channel forming peptides |
| 12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
| 12/27/2007 | US20070298492 Novel PTH responsive gene |
| 12/27/2007 | US20070298491 Human Secreted Proteins |
| 12/27/2007 | US20070298490 or a protein or polypeptide substantially similar thereto, derived from the thermophilic fungus Talaromyces thermophilus; use as a surface coating of materials to provide beneficial properties |
| 12/27/2007 | US20070298489 Expression vector comprising nucleotide sequences coding epidermal growth factor for use in identifying modulators for treatment and prevention of autoimmune, diabetic, bone, infectious and arthritic disorders |
| 12/27/2007 | US20070298473 Pet family of efflux proteins |
| 12/27/2007 | US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis |
| 12/27/2007 | US20070298466 Method For The Construction Of Randomized Gene Sequence Libraries In Cells |
| 12/27/2007 | US20070298464 Methods of producing erythropoietin isoforms comprising Lewis-X structures and high sialic acid content and compositions of the same |
| 12/27/2007 | US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 12/27/2007 | US20070298460 Novel receptor that causes cell death |
| 12/27/2007 | US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease |
| 12/27/2007 | US20070298449 Utilization of Cell Forcibly Expressing Toll-Like Receptor |
| 12/27/2007 | US20070298437 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a chloride intracellular channel 1 protein |
| 12/27/2007 | US20070298434 Library of Toxin Mutants, and Methods of Using Same |
| 12/27/2007 | US20070298424 Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer |
| 12/27/2007 | US20070298412 Fluorescent Proteins And Chromoproteins From Non-Aequorea Hydrozoa Species And Methods For Using Same |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298120 Photoreactive Compound Specifically Binding to Calcium Binding Proteins |
| 12/27/2007 | US20070298055 Vaccine composition comprising non-human, mammalian 5T4 antigen for prevention of cell proliferative disorders |
| 12/27/2007 | US20070298053 Cattle reproductive disease vaccines |
| 12/27/2007 | US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos) |
| 12/27/2007 | US20070298046 Identifying T-cells in a sample that become activated in the presence of an amino acid sequence of a peptide with the same function as a CD8 T cell epitope of a vaccinia or variola virus; diagnosing vaccinia or variola virus infection by determining if the T-cells are activated by the peptide |
| 12/27/2007 | US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same |
| 12/27/2007 | US20070298037 administering antagonist to ztnfr14 comprising antibodies, antibody fragments, proteins or polypeptides, for the treatment of psoriasis, inflammatory bowel disease or multiple sclerosis in mammals |
| 12/27/2007 | US20070298036 PRO71238 Polypeptides |
| 12/27/2007 | US20070298026 Methods for Identifying Treatment and Inducing Infertility Using Smc1-Beta |
| 12/27/2007 | US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use |
| 12/27/2007 | DE19964386B4 Screening drugs disrupting macrophage migration inhibitory factor-cJun activation domain binding protein1 interaction involves comparing MIF-Jab1 interaction, in presence and absence of drug in MIF and Jab1 system |
| 12/27/2007 | DE102006029620A1 Polynucleotides useful for producing plants with increased cold and salt stress resistance are derived from the marine diatom Fragilariopsis cylindrus |
| 12/27/2007 | DE102005063438A1 Verfahren zur Herstellung von porösen Schwämmen aus gereinigtem marinem Kollagen A process for producing porous sponges of purified marine collagen |
| 12/27/2007 | DE10196235B4 Using collagen from aquatic animals as carriers for tissue engineering, useful e.g. as skin replacements and in screening for antiaging drugs |
| 12/27/2007 | CA2826738A1 Polynucleotides and polypeptide sequences involved in cancer |
| 12/27/2007 | CA2659124A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 12/27/2007 | CA2656923A1 Crystal structures of ox40l and ox40l complexed with ox40 receptor |
| 12/27/2007 | CA2656313A1 Ps4 exoamylase h307k/r variant |
| 12/27/2007 | CA2656258A1 Use of plant chromatin remodeling genes for modulating plant architecture and growth |
| 12/27/2007 | CA2656063A1 Targeting complement factor h for treatment of diseases |
| 12/27/2007 | CA2655957A1 Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells |
| 12/27/2007 | CA2655946A1 Antigenic surface structure of sperm cells associated with the y chromosome |
| 12/27/2007 | CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer |
| 12/27/2007 | CA2655871A1 Thrombopoietic compounds |
| 12/27/2007 | CA2655379A1 Structure of the insulin receptor ectodomain |
| 12/27/2007 | CA2654175A1 Fermentation and purification of actinomadura chromoprotein and related species |
| 12/27/2007 | CA2652461A1 Antifungal polypeptides and uses therof in inducing fungal resistance in plants |
| 12/26/2007 | EP1870711A1 Marker protein for use in diagnosis of pancreatic cancer |
| 12/26/2007 | EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870464A2 Methods and compositions for inhibiting neoplastic cell growth |
| 12/26/2007 | EP1870460A1 Methods of producing proteins having triple-helix structure |
| 12/26/2007 | EP1870423A1 Y chromosom related to surface antigen on spermatic cells |
| 12/26/2007 | EP1870421A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
| 12/26/2007 | EP1870420A1 Peptides regulating the surface expression of the T cell receptor |
| 12/26/2007 | EP1870419A2 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 12/26/2007 | EP1870418A1 Allorestricted peptide-specific T cells |
| 12/26/2007 | EP1870417A2 Peptide acceptor ligation methods |
| 12/26/2007 | EP1870115A1 Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |
| 12/26/2007 | EP1869464A2 Rage/diaphanous interaction and related compositions and methods |
| 12/26/2007 | EP1869225A2 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus |
| 12/26/2007 | EP1869209A2 Traceability of cellular cycle anomalies targeting oncology and neurodegeneration |
| 12/26/2007 | EP1869191A1 Novel neural cell specific promoter and baculovirus and method for gene delivery |
| 12/26/2007 | EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer |
| 12/26/2007 | EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
| 12/26/2007 | EP1869172A2 Branched-chain amino acid aminotransferase gene and use thereof |
| 12/26/2007 | EP1869160A2 Gene inactivated mutants with altered protein production |
| 12/26/2007 | EP1869086A1 Methods and compositions for modulating and detecting wisp activity |
| 12/26/2007 | EP1869082A2 Coagulation and fibrinolytic cascades modulator |
| 12/26/2007 | EP1869081A2 POP2 NFkB-INHIBITING POLYPEPTIDES, NUCLEIC ACIDS AND METHODS OF USE |
| 12/26/2007 | EP1869080A2 Human leptin-derived polypeptides and uses thereof |
| 12/26/2007 | EP1869079A2 Di-polymer protein conjugates and processes for their preparation |
| 12/26/2007 | EP1869077A2 Q3 sparc deletion mutant and uses thereof |
| 12/26/2007 | EP1869076A2 Methods and compositions for modulating vascular integrity |
| 12/26/2007 | EP1869075A2 Anti-angiogenic methods and compositions |
| 12/26/2007 | EP1869074A1 Lipocalin protein |
| 12/26/2007 | EP1869073A2 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 12/26/2007 | EP1869072A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 12/26/2007 | EP1869071A2 Tnf-alpha binding polypeptide, uses thereof and methods employing it |
| 12/26/2007 | EP1869070A2 Hgf beta chain variants |
| 12/26/2007 | EP1869066A1 Peptide synthesis of alpha-helixes on peg resin |
| 12/26/2007 | EP1868698A1 Use of proteins as demulsifying agents |
| 12/26/2007 | EP1868654A2 Seneca valley virus based compositions and methods for treating disease |